Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer and is histochemically recognized by the negative expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER‐2).1 This evidence concerns the gene ESR1 and breast cancer.